Group One Trading, L.P. Ab Cellera Biologics Inc. Transaction History

Group One Trading, L.P.

$2.81 Billion
Q3 2025

A detailed history of Group One Trading, L.P. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 121,023 shares of ABCL stock, worth $446,574. This represents 0.02% of its overall portfolio holdings.

Number of Shares

121,023

Previous 131,090 7.68%

Holding current value

$446,574

Previous $449,000 35.41%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.49 - $5.15 $35,133 - $51,845	-10,067 Reduced 7.68%	121,023 $608,000
Q2 2025 Aug 13, 2025	BUY	$1.93 - $3.8 $97,115 - $191,212	50,319 Added 62.3%	131,090 $449,000
Q1 2025 May 14, 2025	SELL	$2.2 - $3.53 $18,552 - $29,768	-8,433 Reduced 9.45%	80,771 $180,000
Q4 2024 Feb 14, 2025	BUY	$2.48 - $3.15 $35,265 - $44,793	14,220 Added 18.96%	89,204 $261,000
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $133,861 - $195,471	56,009 Added 295.17%	74,984 $194,000

Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $37,674 - $65,274	-13,800 Reduced 42.11%	18,975 $56,000
Q1 2024 May 10, 2024	BUY	$4.29 - $5.97 $47,623 - $66,272	11,101 Added 51.22%	32,775 $148,000
Q4 2023 Feb 14, 2024	SELL	$3.91 - $5.93 $146,429 - $222,078	-37,450 Reduced 63.34%	21,674 $123,000
Q3 2023 Nov 09, 2023	BUY	$4.6 - $7.95 $257,199 - $444,508	55,913 Added 1741.3%	59,124 $271,000
Q2 2023 Aug 09, 2023	SELL	$5.66 - $7.59 $76,036 - $101,964	-13,434 Reduced 80.71%	3,211 $20,000
Q1 2023 May 12, 2023	SELL	$7.31 - $11.18 $295,645 - $452,163	-40,444 Reduced 70.84%	16,645 $125,000
Q4 2022 Feb 09, 2023	BUY	$9.48 - $14.52 $433,965 - $664,682	45,777 Added 404.68%	57,089 $578,000
Q3 2022 Nov 09, 2022	SELL	$9.2 - $13.68 $570,179 - $847,831	-61,976 Reduced 84.57%	11,312 $112,000
Q2 2022 Aug 11, 2022	BUY	$5.72 - $10.65 $419,207 - $780,517	73,288 New	73,288 $781,000
Q1 2022 May 12, 2022	SELL	$7.46 - $14.14 $630,601 - $1.2 Million	-84,531 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.99 - $17.73 $1.1 Million - $1.5 Million	84,531 New	84,531 $1.21 Million
Q3 2021 Nov 12, 2021	SELL	$14.85 - $21.34 $285,446 - $410,197	-19,222 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$20.19 - $34.17 $388,092 - $656,815	19,222 New	19,222 $423,000

Others Institutions Holding ABCL

# of Institutions

169

Shares Held

109M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Ab Cellera Biologics Inc. Transaction History